Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

John D Fisk

Showing results (71-80 of 186) with videos related to

Pageof 19
Sort By:
Frontiers in Immunology|June 16, 2023
Etiology, effects and management of comorbidities in multiple sclerosis: recent advancesRuth Ann Marrie, John D Fisk, Kathryn Fitzgerald, et al.
Neurology|November 10, 2017
Comorbidity increases the risk of relapse in multiple sclerosis: A prospective studyKaarina Kowalec, Kyla A McKay, Scott B Patten, et al.
Neurology|November 1, 2015
Differences in the burden of psychiatric comorbidity in MS vs the general populationRuth Ann Marrie, John D Fisk, Helen Tremlett, et al.
Chemico-Biological Interactions|February 4, 2010
Butyrylcholinesterase activity in multiple sclerosis neuropathologySultan Darvesh, Andrea M Leblanc, Ian R Macdonald, et al.
Multiple Sclerosis (Houndmills, Basingstoke, England)|March 10, 2017
Infection-related health care utilization among people with and without multiple sclerosisJosé Ma Wijnands, Elaine Kingwell, Feng Zhu, et al.
Journal of Alzheimer'S Disease : JAD|October 6, 2011
An MRI brain atrophy and lesion index to assess the progression of structural changes in Alzheimer's disease, mild cognitive impairment, and normal aging: a follow-up studyNingnannan Zhang, Xiaowei Song, Yunting Zhang, et al.
Frontiers in Aging Neuroscience|January 29, 2019
Relationship Between DTI Metrics and Cognitive Function in Alzheimer's DiseaseChantel D Mayo, Mauricio A Garcia-Barrera, Erin L Mazerolle, et al.
Multiple Sclerosis (Houndmills, Basingstoke, England)|July 1, 2016
Determinants of non-adherence to disease-modifying therapies in multiple sclerosis: A cross-Canada prospective studyKyla A McKay, Helen Tremlett, Scott B Patten, et al.
The Canadian Journal of Neurological Sciences. Le Journal Canadien Des Sciences Neurologiques|November 22, 2013
The incidence and prevalence of multiple sclerosis in Nova Scotia, CanadaRuth Ann Marrie, John D Fisk, Karen J Stadnyk, et al.
Neurology|March 11, 2018
Psychiatric comorbidity is associated with disability progression in multiple sclerosisKyla A McKay, Helen Tremlett, John D Fisk, et al.
Pageof 19

Showing results (71-80 of 186) with videos related to

Sort By:
Pageof 19
Frontiers in Immunology|June 16, 2023
Etiology, effects and management of comorbidities in multiple sclerosis: recent advancesRuth Ann Marrie, John D Fisk, Kathryn Fitzgerald, et al.
Neurology|November 10, 2017
Comorbidity increases the risk of relapse in multiple sclerosis: A prospective studyKaarina Kowalec, Kyla A McKay, Scott B Patten, et al.
Neurology|November 1, 2015
Differences in the burden of psychiatric comorbidity in MS vs the general populationRuth Ann Marrie, John D Fisk, Helen Tremlett, et al.
Chemico-Biological Interactions|February 4, 2010
Butyrylcholinesterase activity in multiple sclerosis neuropathologySultan Darvesh, Andrea M Leblanc, Ian R Macdonald, et al.
Multiple Sclerosis (Houndmills, Basingstoke, England)|March 10, 2017
Infection-related health care utilization among people with and without multiple sclerosisJosé Ma Wijnands, Elaine Kingwell, Feng Zhu, et al.
Journal of Alzheimer'S Disease : JAD|October 6, 2011
An MRI brain atrophy and lesion index to assess the progression of structural changes in Alzheimer's disease, mild cognitive impairment, and normal aging: a follow-up studyNingnannan Zhang, Xiaowei Song, Yunting Zhang, et al.
Frontiers in Aging Neuroscience|January 29, 2019
Relationship Between DTI Metrics and Cognitive Function in Alzheimer's DiseaseChantel D Mayo, Mauricio A Garcia-Barrera, Erin L Mazerolle, et al.
Multiple Sclerosis (Houndmills, Basingstoke, England)|July 1, 2016
Determinants of non-adherence to disease-modifying therapies in multiple sclerosis: A cross-Canada prospective studyKyla A McKay, Helen Tremlett, Scott B Patten, et al.
The Canadian Journal of Neurological Sciences. Le Journal Canadien Des Sciences Neurologiques|November 22, 2013
The incidence and prevalence of multiple sclerosis in Nova Scotia, CanadaRuth Ann Marrie, John D Fisk, Karen J Stadnyk, et al.
Neurology|March 11, 2018
Psychiatric comorbidity is associated with disability progression in multiple sclerosisKyla A McKay, Helen Tremlett, John D Fisk, et al.
Pageof 19